Literature DB >> 25908663

Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4⁺ T cells.

Matthew R Hepworth1, Thomas C Fung2, Samuel H Masur3, Judith R Kelsen3, Fiona M McConnell4, Juan Dubrot5, David R Withers4, Stephanie Hugues5, Michael A Farrar6, Walter Reith5, Gérard Eberl7, Robert N Baldassano3, Terri M Laufer8, Charles O Elson9, Gregory F Sonnenberg10.   

Abstract

Inflammatory CD4(+) T cell responses to self or commensal bacteria underlie the pathogenesis of autoimmunity and inflammatory bowel disease (IBD), respectively. Although selection of self-specific T cells in the thymus limits responses to mammalian tissue antigens, the mechanisms that control selection of commensal bacteria-specific T cells remain poorly understood. Here, we demonstrate that group 3 innate lymphoid cell (ILC3)-intrinsic expression of major histocompatibility complex class II (MHCII) is regulated similarly to thymic epithelial cells and that MHCII(+) ILC3s directly induce cell death of activated commensal bacteria-specific T cells. Further, MHCII on colonic ILC3s was reduced in pediatric IBD patients. Collectively, these results define a selection pathway for commensal bacteria-specific CD4(+) T cells in the intestine and suggest that this process is dysregulated in human IBD.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25908663      PMCID: PMC4449822          DOI: 10.1126/science.aaa4812

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  41 in total

Review 1.  A new vision of immunity: homeostasis of the superorganism.

Authors:  G Eberl
Journal:  Mucosal Immunol       Date:  2010-05-05       Impact factor: 7.313

Review 2.  Intestinal dendritic cells.

Authors:  Maria Rescigno
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

Review 3.  Regulation of MHC class II gene expression by the class II transactivator.

Authors:  Walter Reith; Salomé LeibundGut-Landmann; Jean-Marc Waldburger
Journal:  Nat Rev Immunol       Date:  2005-10       Impact factor: 53.106

Review 4.  Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications.

Authors:  J Mudter; M F Neurath
Journal:  Gut       Date:  2006-09-06       Impact factor: 23.059

Review 5.  Aire.

Authors:  Diane Mathis; Christophe Benoist
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 6.  The mucosal firewalls against commensal intestinal microbes.

Authors:  Andrew J Macpherson; Emma Slack; Markus B Geuking; Kathy D McCoy
Journal:  Semin Immunopathol       Date:  2009-08-26       Impact factor: 9.623

7.  A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota.

Authors:  Yingzi Cong; Ting Feng; Kohtaro Fujihashi; Trenton R Schoeb; Charles O Elson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-04       Impact factor: 11.205

Review 8.  Intestinal homeostasis and its breakdown in inflammatory bowel disease.

Authors:  Kevin J Maloy; Fiona Powrie
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

Review 9.  Inflammatory bowel disease.

Authors:  Arthur Kaser; Sebastian Zeissig; Richard S Blumberg
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

Review 10.  Checkpoints in lymphocyte development and autoimmune disease.

Authors:  Harald von Boehmer; Fritz Melchers
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

View more
  200 in total

Review 1.  ROS in gastrointestinal inflammation: Rescue Or Sabotage?

Authors:  G Aviello; U G Knaus
Journal:  Br J Pharmacol       Date:  2016-03-03       Impact factor: 8.739

2.  Liraglutide targets the gut microbiota and the intestinal immune system to regulate insulin secretion.

Authors:  Julie Charpentier; Francois Briand; Benjamin Lelouvier; Florence Servant; Vincent Azalbert; Anthony Puel; Jeffrey E Christensen; Aurélie Waget; Maxime Branchereau; Céline Garret; Jérome Lluch; Christophe Heymes; Emmanuel Brousseau; Rémy Burcelin; Laurence Guzylack; Thierry Sulpice; Estelle Grasset
Journal:  Acta Diabetol       Date:  2021-03-15       Impact factor: 4.280

Review 3.  Innate-like lymphocytes in intestinal infections.

Authors:  Michael S Bennett; June L Round; Daniel T Leung
Journal:  Curr Opin Infect Dis       Date:  2015-10       Impact factor: 4.915

4.  Gut Microbiota-Derived Short-Chain Fatty Acids Promote Poststroke Recovery in Aged Mice.

Authors:  Juneyoung Lee; John d'Aigle; Louise Atadja; Victoria Quaicoe; Pedram Honarpisheh; Bhanu P Ganesh; Ahmad Hassan; Joerg Graf; Joseph Petrosino; Nagireddy Putluri; Liang Zhu; David J Durgan; Robert M Bryan; Louise D McCullough; Venugopal Reddy Venna
Journal:  Circ Res       Date:  2020-05-01       Impact factor: 17.367

Review 5.  Human microbiota, blood group antigens, and disease.

Authors:  D Rose Ewald; Susan C J Sumner
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2018-01-09

Review 6.  Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases.

Authors:  Medya M Shikhagaie; Kristine Germar; Suzanne M Bal; Xavier Romero Ros; Hergen Spits
Journal:  Nat Rev Rheumatol       Date:  2017-02-02       Impact factor: 20.543

7.  Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserved Heterogeneity in Culture.

Authors:  Kien Pham; Daniel Delitto; Andrea E Knowlton; Emily R Hartlage; Ricky Madhavan; David H Gonzalo; Ryan M Thomas; Kevin E Behrns; Thomas J George; Steven J Hughes; Shannon M Wallet; Chen Liu; Jose G Trevino
Journal:  Am J Pathol       Date:  2016-04-18       Impact factor: 4.307

8.  Copycat innate lymphoid cells dampen gut inflammation.

Authors:  Giuliana Magri; Andrea Cerutti
Journal:  Cell Res       Date:  2015-06-26       Impact factor: 25.617

Review 9.  The balance of power: innate lymphoid cells in tissue inflammation and repair.

Authors:  Jim G Castellanos; Randy S Longman
Journal:  J Clin Invest       Date:  2019-06-10       Impact factor: 14.808

10.  ILC3-derived OX40L is essential for homeostasis of intestinal Tregs in immunodeficient mice.

Authors:  Tian Deng; Caixia Suo; Jiali Chang; Rui Yang; Jingyu Li; Ting Cai; Ju Qiu
Journal:  Cell Mol Immunol       Date:  2019-02-13       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.